NZ226475A - Soluble hcd4 (t4) t-lymphocyte surface glycoprotein that binds hiv gp120 envelope protein - Google Patents

Soluble hcd4 (t4) t-lymphocyte surface glycoprotein that binds hiv gp120 envelope protein

Info

Publication number
NZ226475A
NZ226475A NZ226475A NZ22647588A NZ226475A NZ 226475 A NZ226475 A NZ 226475A NZ 226475 A NZ226475 A NZ 226475A NZ 22647588 A NZ22647588 A NZ 22647588A NZ 226475 A NZ226475 A NZ 226475A
Authority
NZ
New Zealand
Prior art keywords
human
protein
fragment
hiv
amino acid
Prior art date
Application number
NZ226475A
Other languages
English (en)
Inventor
Rebecca Hussey
Ellis Reinherz
Linda K Clayton
Joseph Sodroski
Neil Richardson
Original Assignee
Dana Farber Cancer Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/217,475 external-priority patent/US5109123A/en
Application filed by Dana Farber Cancer Inst Inc filed Critical Dana Farber Cancer Inst Inc
Publication of NZ226475A publication Critical patent/NZ226475A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NZ226475A 1987-10-08 1988-10-06 Soluble hcd4 (t4) t-lymphocyte surface glycoprotein that binds hiv gp120 envelope protein NZ226475A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US10618587A 1987-10-08 1987-10-08
US14431388A 1988-01-14 1988-01-14
US20658588A 1988-06-14 1988-06-14
US07/217,475 US5109123A (en) 1988-06-14 1988-07-11 Alteration of ability of soluble CD4 fragments to bind HIV

Publications (1)

Publication Number Publication Date
NZ226475A true NZ226475A (en) 1991-03-26

Family

ID=27493499

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ226475A NZ226475A (en) 1987-10-08 1988-10-06 Soluble hcd4 (t4) t-lymphocyte surface glycoprotein that binds hiv gp120 envelope protein

Country Status (9)

Country Link
EP (1) EP0400010A1 (ja)
JP (1) JPH03504234A (ja)
AU (1) AU2614888A (ja)
DK (1) DK87490A (ja)
ES (1) ES2012129A6 (ja)
GR (1) GR1000850B (ja)
IL (1) IL87902A0 (ja)
NZ (1) NZ226475A (ja)
WO (1) WO1989003222A1 (ja)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637677A (en) 1987-07-16 1997-06-10 The Trustees Of The University Of Pennsylvania Biologically active compounds and methods of constructing and using the same
ZA887365B (en) * 1987-10-02 1990-05-30 Genentech Inc Adheson variants
US5206353A (en) * 1988-07-23 1993-04-27 The United States Of America As Represented By The Department Of Health And Human Services CD-4/cytotoxic gene fusions
AU623924B2 (en) * 1988-07-22 1992-05-28 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Cytotoxic agent against specific virus infection
EP0408372A1 (en) * 1989-07-13 1991-01-16 Smithkline Beecham Corporation Anti-viral therapy
WO1991002743A1 (en) * 1989-08-23 1991-03-07 The General Hospital Corporation Non-human primate cd4 polypeptides, fusions thereof, dna encoding, and uses thereof
US5614612A (en) * 1990-03-09 1997-03-25 Haigwood; Nancy L. Purified gp120 compositions retaining natural conformation
JPH0725794B2 (ja) * 1990-03-23 1995-03-22 呉羽化学工業株式会社 新規なペプチド
EP0551440B1 (en) * 1990-09-14 2002-12-18 The Trustees Of The University Of Pennsylvania Design of bioactive peptides based on immunoglobulin structure
AU1438592A (en) * 1991-02-08 1992-09-07 Progenics Pharmaceuticals, Inc. Cd4-gamma1 and cd4-igg1 chimeras
CA2080226C (en) 1991-02-08 2004-05-04 Gary A. Beaudry Cd4-gamma2 and cd4-igg2 chimeras
US7070991B2 (en) 1991-02-08 2006-07-04 Progenics Pharmaceuticals, Inc. Cells expressing a CD4-IgG2 chimeric heterotetramer
US5234905A (en) * 1991-02-22 1993-08-10 University Of Colorado Foundation, Inc. Soluble CD4 molecules modified to prolong circulating half-life
EP0510483A1 (en) * 1991-04-22 1992-10-28 Boehringer Ingelheim Pharmaceuticals Inc. Method for the detection of viruses
DE69938062T2 (de) 1998-12-31 2009-01-15 Novartis Vaccines and Diagnostics, Inc., Emeryville Modifizierte hiv env polypeptide
US7935805B1 (en) 1998-12-31 2011-05-03 Novartis Vaccines & Diagnostics, Inc Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof
JP2003523721A (ja) 1998-12-31 2003-08-12 カイロン コーポレイション 抗原性ｈｉｖｃ型ポリペプチドをコードするポリヌクレオチド、ポリペプチド、およびそれらの使用
US20030194800A1 (en) 2001-08-31 2003-10-16 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
JP2002533124A (ja) 1998-12-31 2002-10-08 カイロン コーポレイション Ｈｉｖポリペプチドの改善された発現およびウイルス様粒子の生成
AU2002320314A1 (en) 2001-07-05 2003-01-21 Chiron, Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
US20160039904A1 (en) 2013-03-15 2016-02-11 The United States Of America, As Represented By The Secretary, Department Of Health And Human Serv Stabilized single human cd4 domains and fusion proteins
WO2017055522A1 (en) 2015-09-29 2017-04-06 Academisch Medisch Centrum Stabilized env proteins of hiv

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988001304A1 (en) * 1986-08-21 1988-02-25 The Trustees Of Columbia University In The City Of Dna encoding the t cell surface protein t4 and use of fragments of t4 in the treatment of aids
NZ226414A (en) * 1987-10-02 1992-07-28 Genentech Inc Cd4 peptide adhesion variants and their preparation and use

Also Published As

Publication number Publication date
ES2012129A6 (es) 1990-03-01
DK87490A (da) 1990-06-08
EP0400010A1 (en) 1990-12-05
IL87902A0 (en) 1989-03-31
AU2614888A (en) 1989-05-02
DK87490D0 (da) 1990-04-06
JPH03504234A (ja) 1991-09-19
WO1989003222A1 (en) 1989-04-20
GR1000850B (el) 1993-02-17

Similar Documents

Publication Publication Date Title
NZ226475A (en) Soluble hcd4 (t4) t-lymphocyte surface glycoprotein that binds hiv gp120 envelope protein
Hussey et al. A soluble CD4 protein selectively inhibits HIV replication and syncytium formation
US5109123A (en) Alteration of ability of soluble CD4 fragments to bind HIV
Jones et al. Isolation of complementary DNA clones encoding the human lymphocyte glycoprotein T1/Leu-1
US5874250A (en) DNA encoding for a protein containing the extracellular domain of lymphocyte activation gene 3
US6570000B1 (en) DNA encoding the T cell surface protein CD4 and use of fragments of CD4 in the treatment of AIDS
CA2182890C (en) Targeted cytolysis of hiv-infected cells by chimeric cd4 receptor-bearing cells
JP3166854B2 (ja) 細胞間粘着分子の官能性誘導体を用いた抗ウィルス剤
US5276016A (en) Small peptides which inhibit binding to T-4 receptors and act as immunogens
EP0428602A1 (en) POLYPEPTIDES AND ENCODING DNA.
EP0249390A2 (en) Synthetic peptides related to the HIV glycoprotein gp 120
CA2131153C (en) Peptides stimulating cytotoxic lymphocytes response to hiv-i gp 160
US5686582A (en) Multimeric forms of human rhinovirus receptor protein
AU673810B2 (en) Secreted Mac-2-binding glycoprotein
JPH03505039A (ja) 可溶性ｃｄ４を発現するレトロウイルスベクター、エイズの遺伝子治療法
EP0249394B1 (en) Small peptides which inhibit binding to T-4 receptors and act as immunogens
IL91070A (en) Cytotoxic agents against certain viral infections
WO1991017179A1 (en) Peptide analogs to proteins of the immunoglobulin superfamily
WO1999020761A2 (en) Compositions and methods for identifying and testing therapeutics against hsv infection
US5874264A (en) Gibbon ape leukemia virus receptor
US6107461A (en) Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use
JP2680011B2 (ja) Ｔ−４レセプターへの結合を阻害し免疫原として作用する小ペプチド類
WO1997030081A1 (en) Ebna2 peptides and methods of using same
AP96A (en) Small peptides which inhibit binding to T-4 receptors and act as immunogens.
THOMAS et al. Dissecting the Basis for Its Inhibitory Effect on HIV-Induced Cell Fusion